Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.20 (0.349%)
Market Cap: £2.52b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Acquisition

16 Sep 2019 16:13

RNS Number : 5023M
TP ICAP PLC
16 September 2019
Β 

16 September 2019

Β 

TP ICAP acquires ClearCompress

Expansion into innovative compression services

Β 

TP ICAP plc ("TP ICAP" or "the Company") today announces that it has acquired ClearCompress Limited ("ClearCompress"), a provider of innovative, algorithm-based, light-touch compression services in cleared and uncleared derivatives that assist clients to achieve cost efficiencies and capital reduction.

Β 

TP ICAP and ClearCompress started collaborating in 2017. At that time, ClearCompress contributed development and algorithm expertise and TP ICAP contributed access to clients and support infrastructure. The parties deepened their relationship in March 2019 when TP ICAP agreed to provide funding of Β£500,000 and the benefit of its regulated status to ClearCompress. The parties have now agreed to formalise their relationship with the acquisition of ClearCompress by TP ICAP. The key team members of ClearCompress, including David Hill, the CEO, will remain with the business and continue to expand its client base and service range.

Β 

The sellers of ClearCompress are the founders, early-stage investors and management team. The consideration for the acquisition is Β£750,000 in cash to be paid over 2 years, and performance-related payments for the 6 years starting 1 September 2019 until 31 August 2025 based on the revenues of the business, payable annually in cash or shares at the discretion of TP ICAP.

Β 

The gross assets of ClearCompress at 31 January 2019 were Β£88,152 and the business reported a loss before tax of Β£346,606 for the year ended 31 January 2019.

Β 

Nicolas Breteau, CEO of TP ICAP, said, "The acquisition of ClearCompress is in line with our strategy to broaden our customer service offering. The compression runs we have conducted demonstrate excellent outcomes for our clients. We are delighted to welcome this innovative company with its expertise in algo-driven capital optimisation solutions to our group and we are excited to move forward and grow the business together."

Β 

David Hill, CEO of ClearCompress, said, "As ClearCompress enters the next phase in its development, we are looking forward to being a part of the TP ICAP Group which will enable us to accelerate our client reach, develop new products and expand internationally. Our partnership with TP ICAP and the solutions we deliver have been well received by clients and we are enthusiastic and confident about what more we can do in the future."

Β 

ENDS

Β 

Enquiries:

Β 

TP ICAP:

Analysts and Investors

Al Alevizakos

Alevizos.Alevizakos@tpicap.com

+44 (0) 203 933 3040

Β 

Media

William Baldwin-Charles

William.Baldwin-Charles@tpicap.comΒ 

+44 (0) 20 7200 7124

Β 

About TPICAP

TP ICAP brings together buyers and sellers in global financial, energy and commodities markets. It is the world's largest wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world. We operate from offices in 31 countries, supporting award-winning brokers with market-leading technology.

www.tpicap.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
ACQCKADDPBKDBCD
Date   Source Headline
26th Mar 20181:26 pmRNSAllotment of consideration shares
26th Mar 201811:01 amRNSDirector/PDMR Shareholding
14th Mar 20185:19 pmRNSDirector/PDMR Shareholding
13th Mar 20187:00 amRNSFinal Results
8th Jan 20187:00 amRNSAcquisition
5th Jan 20181:24 pmRNSTotal Voting Rights
5th Jan 20187:00 amRNSNotice of Results
15th Dec 20177:00 amRNSDirector/PDMR Shareholding
8th Dec 201712:52 pmRNSHolding(s) in Company
8th Dec 20177:00 amRNSDirectorate Change
30th Nov 20177:00 amRNSAcquisition of Coex Partners Limited
30th Nov 20177:00 amRNSCapital Markets Update
29th Nov 20173:45 pmRNSDirector/PDMR Shareholding
23rd Nov 20174:26 pmRNSHolding(s) in Company
22nd Nov 201711:54 amRNSHolding(s) in Company
3rd Nov 20177:00 amRNS3rd Quarter Trading Update
17th Oct 20177:00 amRNSDirectorate Change
5th Oct 20179:58 amRNSHolding(s) in Company
29th Sep 20178:21 amRNSHolding(s) in Company
22nd Sep 20173:58 pmRNSHolding(s) in Company
22nd Sep 201712:28 pmRNSHolding(s) in Company
30th Aug 20173:33 pmRNSHolding(s) in Company
8th Aug 20177:00 amRNSFinancial and Interim Management Report
17th Jul 201710:33 amRNSHolding(s) in Company
14th Jul 201712:38 pmRNSHolding(s) in Company
22nd Jun 20179:53 amRNSHolding(s) in Company
16th Jun 201711:37 amRNSHolding(s) in Company
22nd May 20173:02 pmRNSDirector/PDMR Shareholding
15th May 20172:52 pmRNSDirector/PDMR Shareholding
11th May 20174:45 pmRNSResult of Annual General Meeting
11th May 20177:02 amRNSBalance Sheet Strengthens with £270m Bulk Annuity
11th May 20177:00 amRNSAGM Statement and Trading Update
6th Apr 201711:00 amRNSAnnual Financial Report
5th Apr 201711:57 amRNSDirector/PDMR Shareholding
27th Mar 20174:41 pmRNSDirector/PDMR Shareholding
14th Mar 20177:00 amRNSFinal Results
28th Feb 201712:27 pmRNSNotice of Results
21st Feb 20179:29 amRNSHolding(s) in Company
24th Jan 20176:04 pmRNSTP ICAP GBP 7yr - Post-Stabilisation Notice
24th Jan 20174:42 pmRNSPublication of Final Terms
19th Jan 20175:29 pmRNSIssue of £500m Fixed Rate Senior Unsecured Notes
19th Jan 20178:39 amRNSTP ICAP GBP 7yr - Pre-Stabilisation Notice
18th Jan 201711:03 amRNSPublication of a Prospectus
16th Jan 20176:06 pmRNSHolding(s) in Company
12th Jan 20174:47 pmRNSHolding(s) in Company
12th Jan 20174:42 pmRNSHolding(s) in Company
12th Jan 20174:28 pmRNSHolding(s) in Company
10th Jan 201710:12 amRNSHolding(s) in Company
6th Jan 201710:54 amRNSPublication of a Prospectus
6th Jan 20177:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.